Skip to main content
Amgen10-Q: Inflation impact

Amgen's ENBREL net price drops 22% due to IRA Medicare price setting

What happened

The Inflation Reduction Act (IRA) is directly eroding Amgen's revenue, causing a 22% drop in ENBREL's net selling price in Q2 2026. This regulatory pressure, which will also affect Otezla starting in 2027, forces the company to find new efficiencies and manage the profitability of major products.

Source

SEC EDGARAug 4, 2026

Quarterly report (Form 10-Q)

Amgen 10-Q

Filing excerpt

The decrease in ENBREL sales for the three months ended June 30, 2026 was primarily driven by lower net selling price of 22% resulting from the impact of U.S. Medicare Part D price setting under the IRA, effective January 1, 2026...

sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htmRead the full source

Other signals in this filing (7)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Inflation impact

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
06/30
Filed
Aug 4, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Percent
-22% (ENBREL net selling price decrease due to IRA)

Details

CIK
318154
Accession number
0000318154-26-000126
Timeframe
Current quarter
Filing year
2026
Fiscal year
0
Why it matters
Efficiency tools needed
Signal category
Operations

Topics and mentions

Regions named

  • United States

Extraction

Confidence
High
Relevance
90%
Sentiment
Negative
Detected
Aug 11, 2026
signal_type
sec-10q
signal_subtype
inflationImpact

Use this data

Get every 10-Q signal for Amgen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Amgen this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/6b204de3-b4bc-4a3e-b586-c0bd39928994 returns this record as JSON. POST /v1/companies/enrich returns every signal for amgen.com.

{
  "signal_id": "6b204de3-b4bc-4a3e-b586-c0bd39928994",
  "signal_type": "sec-10q",
  "signal_subtype": "inflationImpact",
  "detected_at": "2026-08-11T08:09:12.392+00:00",
  "company": {
    "name": "Amgen",
    "domain": "amgen.com"
  },
  "data": {
    "detail": "The Inflation Reduction Act (IRA) is directly eroding Amgen's revenue, causing a 22% drop in ENBREL's net selling price in Q2 2026. This regulatory pressure, which will also affect Otezla starting in 2027, forces the company to find new efficiencies and manage the profitability of major products.",
    "metrics": {
      "pct": -0.22,
      "timeframe": "current_quarter",
      "pct_context": "ENBREL net selling price decrease due to IRA"
    },
    "summary": "Amgen's ENBREL net price drops 22% due to IRA Medicare price setting",
    "excerpts": "The decrease in ENBREL sales for the three months ended June 30, 2026 was primarily driven by lower net selling price of 22% resulting from the impact of U.S. Medicare Part D price setting under the IRA, effective January 1, 2026...",
    "relevance": 0.9,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/318154/000031815426000126/amgn-20260630.htm",
    "filing_date": "2026-08-04",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "06/30",
    "sales_relevance": "Efficiency tools needed",
    "signal_category": "operations",
    "regions_mentioned": [
      "United States"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.